CTOs on the Move

Novartis

www.novartis.com

 
Novartis provides healthcare solutions that improve and extend people`s lives. We use science-based innovation to address some of society`s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. Our company is focused on industry-leading divisions with innovation power and global scale: pharmaceuticals, eye care and generic medicines Novartis is headquartered in Basel, Switzerland. Novartis Group companies employ approximately 120,000 associates and its products are available in more than 180 countries around the world.
  • Number of Employees: 50K-100K
  • Annual Revenue: > $1 Billion
  • www.novartis.com
  • 1 Health Plaza
    East Hanover, NJ USA 07936
  • Phone: 862.778.8300

Executives

Name Title Contact Details
Charlene Banard
Global Head of Technical Operations, Cell and Gene Therapy Profile
Andreas Muller
Senior Vice President, Global Head Commercial Information Technology and Chief Information Officer Profile
Jinah Jong
Associate Director, Medical Information Profile
Matthew Standart
Global Head of Cyber Security Operations Center Profile
Erik Johnson
Global Service Delivery Manager - Access and Authentication Profile

Similar Companies

Allen and Alice Stokes Nature

Allen and Alice Stokes Nature is a Logan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Pharmacy Examination Board of Canada

The Pharmacy Examination Board of Canada is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aclario

Aclario is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phlow

Securing our nation’s pharmaceuticals through U.S. Manufacturing.

Predictive Oncology

Updates, earnings and commercializationListen to the audio recording of our recent shareholder call where we discussed the latest updates, gave an overview of our earnings report and highlighted the commercialization efforts underway at Predictive Onco...